Palatin Technologies Inc (PTN)

0.33
0.00 1.10
AMEX : Health Care
Prev Close 0.33
Open 0.33
Day Low/High 0.33 / 0.34
52 Wk Low/High 0.36 / 1.18
Volume 942.22K
Avg Volume 2.25M
Exchange AMEX
Shares Outstanding 137.95M
Market Cap 44.14M
EPS -0.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Palatin Technologies Announces Closing Of License Agreement With AMAG Pharmaceuticals For North American Rights To Rekynda™

Palatin Technologies Announces Closing Of License Agreement With AMAG Pharmaceuticals For North American Rights To Rekynda™

Will Also Report Second Quarter 2017 Results and Discuss Next Steps in its Development Programs

How to Trade Today's Most Active Stocks -- Ford, Palatin, More

How to Trade Today's Most Active Stocks -- Ford, Palatin, More

Here's a technical look at how to trade some of the most active stocks on the market right now.

Palatin Female Libido-Boosting Shot Fails Crucial Sex Frequency Test

Palatin Female Libido-Boosting Shot Fails Crucial Sex Frequency Test

Palatin appears be to playing a game of bait and switch with the design of its phase III studies.

Palatin Technologies Presents Bremelanotide Alcohol Interaction Study At International Society For The Study Of Women's Sexual Health Annual Meeting

Palatin Technologies Presents Bremelanotide Alcohol Interaction Study At International Society For The Study Of Women's Sexual Health Annual Meeting

Results of Phase 1 Study Demonstrate No Adverse Events When Bremelanotide is Combined with Ethanol

Insider Trading Alert - AEL, PTN And BSX Traded By Insiders

Insider Trading Alert - AEL, PTN And BSX Traded By Insiders

Stocks with insider trader activity include AEL, PTN and BSX

Palatin Technologies (PTN) Stock Up After FDA Approval of 'Female Viagra'

Palatin Technologies (PTN) Stock Up After FDA Approval of 'Female Viagra'

Palatin Technologies (PTN) shares are rising after the FDA approved the first treatment for low female libido earlier this week.

Palatin Technologies (PTN) Stock Climbing on FDA Approval of 'Female Viagra'

Palatin Technologies (PTN) Stock Climbing on FDA Approval of 'Female Viagra'

Palatin Technologies (PTN) shares are climbing after the FDA approved the first low female libido treatment yesterday.

Palatin Technologies Completes $30 Million Financing

Palatin Technologies Completes $30 Million Financing

$20 Million Equity and $10 Million Debt

Palatin Technologies (PTN) Strong On High Relative Volume Today

Palatin Technologies (PTN) Strong On High Relative Volume Today

Trade-Ideas LLC identified Palatin Technologies (PTN) as a strong on high relative volume candidate